What to do (and what not to do) when your friend or family member gets the diagnosis Getty Key Takeaways Real patients offer advice on how to support loved ones with a metastatic breast cancer ...
Yahoo: Why Many Doctors Now Believe Metastatic Breast Cancer Should Be Treated as a Manageable Chronic Condition
Add Yahoo as a preferred source to see more of our stories on Google. For decades, a diagnosis of metastatic breast cancer—the stage when cancer spreads beyond the breast to distant parts of the ...
Why Many Doctors Now Believe Metastatic Breast Cancer Should Be Treated as a Manageable Chronic Condition
Medscape: Patritumab Deruxtecan Clinically Active Against Metastatic Breast Cancer and Brain Metastases
A single-arm phase 2 trial showed that patritumab deruxtecan (HER3-DXd) demonstrated meaningful clinical activity in pretreated patients with metastatic breast cancer and active brain metastases, ...
—Do Black and White patients with metastatic breast cancer have different genomic profiles, and do they experience inequities in use of targeted therapies and outcomes? That was the question at the ...
WebMD: Factors That Determine the Course of Treatment for HR+/HER2- Metastatic Breast Cancer
After you’re diagnosed with hormone receptor-positive (HR+), HER2-negative metastatic breast cancer, your doctor’s goal is to build a treatment plan that gives you the best chance of controlling your ...
Factors That Determine the Course of Treatment for HR+/HER2- Metastatic Breast Cancer
T-DXd significantly improves progression-free and overall survival compared to T-DM1 in HER2-positive metastatic breast cancer, with a favorable safety profile. Real-world data show T-DXd's ...
Bria-IMT combined with a checkpoint inhibitor improved overall survival in metastatic breast cancer compared to Trodelvy and chemotherapy. In triple-negative breast cancer, Bria-IMT showed a median ...